Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The objective is to support innovative research in pharmacogenomic strategies for personalized medicine, includes identifying and validating pharmacogenomic markers, optimizing treatment outcomes through multi-omics data, and ensuring personalized patient care.
Característiques principals
The EP PerMed JTC2025 is co-funded by the EU and the overall objectives of the JTC2025 are to:
  • Support research projects in human health on pharmacogenomic strategies for personalised medicine approaches that address one or more of the following aspects, identification of new pharmacogenomic , validation pharmacogenomic and use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of drug.
  • Encourage and enable interdisciplinary collaborations by combining pre-clinical and clinical research.
  • Encourage cross-sectorial collaborations, by including the private sector, industry, as well as regulatory/HTA agencies and patient organisations and Establish participatory research.
    • Lloc de presentació
    HMRIB and PSMAR staff who need more information should contact::
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.: 1670
    Marta López: [email protected] Ext.: 1576
    Convocatòria (URL)
    https://www.eppermed.eu/funding-projects/calls/jtc2025/
    https://ptoutline.eu/app/EPPERMED2025
    https://www.eppermed.eu/wp-content/uploads/EPPerMed_JTC2025_Announcement.pdf
    Requisits
  • Only transnational projects will be funded.
  • Each consortium must involve at least three partners from three different EU Member States or Associated Countries 5 whose funding organisations participate in the call (see list above)6. Each of these partners must be eligible and request funding from the respective funding organisation.
  • The project coordinator must be eligible to be funded by his/her regional/national participating funding organisation.
  • Academia (research teams working in universities, other higher education institutions) or research institutes
  • Clinical/public health sector (research teams working in hospitals/public health and/or other healthcare settings and health organisations). Participation of clinicians (e.g. medical doctors, nurses) in the research teams is encouraged
  • Private for-profit (industry) partners, e.g. SME 8 (small and medium-sized enterprises) and private non-profit partners, e.g. foundations, associations or non-governmental organisations.
    • Dotació
    36,5 Mio€
    Durada
    Maximum 3 years.
    AVÍS IMPORTANT
    There will be an informative session on January 9th.

    Submission of pre-proposals: 18 February 2025 at 14:00 (CET)
    Submission of invited full-proposals: 17 June 2025 at 14:00 (CEST)

    Arxius

    Arxiu
    EPPerMed_JTC2025_GuidelinesApplicants.pdf
    EPPerMed_JTC2025_Announcement.pdf
    EPPerMed_JTC2025_Call_Text.pdf
    EPPerMed_JTC2025_pre-proposal_form.docx